BRYNJELSEN SEAN
President & CEO
BRYNJELSEN SEAN has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Aug 20, 2026.
On the most recent filing, BRYNJELSEN SEAN is listed as President & CEO at Eton Pharmaceuticals, Inc. Inside the rolling window, BRYNJELSEN SEAN reported no open-market purchases and 3 open-market sales totaling $9.9M in ETON. The largest disclosed transaction in the window is a sale of 91,022 ETON shares on Aug 20, 2026, worth $5.5M.
Companies traded
Other insiders at ETON
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$9.9M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has BRYNJELSEN SEAN made?
BRYNJELSEN SEAN has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.
Which companies does BRYNJELSEN SEAN trade?
BRYNJELSEN SEAN has filed SEC Form 4 disclosures for 1 company, including ETON.
When was BRYNJELSEN SEAN's most recent SEC Form 4 filing?
BRYNJELSEN SEAN's most recent SEC Form 4 filing on Tracefour is dated Aug 20, 2026.
What is BRYNJELSEN SEAN's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, BRYNJELSEN SEAN is listed as President & CEO.
What is BRYNJELSEN SEAN's total buy and sell value in the current window?
Inside the rolling retention window, BRYNJELSEN SEAN bought $0 and sold $9.9M based on SEC Form 4 filings.
What was BRYNJELSEN SEAN's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 91,022 ETON shares on 2026-08-20, worth $5.5M, per SEC Form 4 filings.